One World Products (OWPC) Income from Continuing Operations (2014 - 2025)
One World Products (OWPC) recorded quarterly Income from Continuing Operations of 635275.0 in Q3 2025, down 138.9% quarter-over-quarter from 265916.0 in Q2 2025, and up 10.81% on a YoY basis from 573321.59 in Q3 2024.
One World Products (OWPC) Income from Continuing Operations (2014 - 2025) Analysis & Trends
One World Products' Income from Continuing Operations history runs 12 years deep, the most recent figure standing at 635275.0 for Q3 2025.
- In Q3 2025, Income from Continuing Operations rose 10.81% year-over-year to 635275.0; the TTM figure through Sep 2025 stood at 1788548.0 (up 44.21% YoY), while the FY2024 annual figure was 2965654.0, down 24.11% from the prior year.
- Income from Continuing Operations was 635275.0 for Q3 2025 at One World Products, down from 265916.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 255666.0 in Q1 2025 to a low of 1277048.0 in Q4 2021.
- Historically, Income from Continuing Operations has averaged 704750.0 across 5 years, with a median of 709441.0 in 2022.
- The sharpest annual moves came in 2021 and 2024: Income from Continuing Operations soared 82.69% in 2021, then tumbled 70.42% in 2024.
- A 5-year view of Income from Continuing Operations shows it stood at 1277048.0 in 2021, then soared by 44.45% to 709441.0 in 2022, then slipped by 22.89% to 871834.0 in 2023, then climbed by 27.54% to 631691.0 in 2024, then slipped by 0.57% to 635275.0 in 2025.
- The last three Income from Continuing Operations figures came in at 635275.0 (Q3 2025), 265916.0 (Q2 2025), and 255666.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 21.05 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | One World Products | - | - | 48,591.00 | -635,275.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -635,275.00 |
| Jun 30, 2025 | -265,916.00 |
| Mar 31, 2025 | -255,666.00 |
| Dec 31, 2024 | -631,691.00 |
| Sep 30, 2024 | -712,240.00 |
| Jun 30, 2024 | -742,459.00 |
| Mar 31, 2024 | -879,264.00 |
| Dec 31, 2023 | -871,834.00 |
| Sep 30, 2023 | -450,306.00 |
| Jun 30, 2023 | -551,527.00 |
| Mar 31, 2023 | -515,938.00 |
| Dec 31, 2022 | -709,441.00 |
| Sep 30, 2022 | -1.01 Mn |
| Jun 30, 2022 | -692,490.00 |
| Mar 31, 2022 | -730,878.00 |
| Dec 31, 2021 | -1.28 Mn |
| Sep 30, 2021 | -655,116.00 |
| Jun 30, 2021 | -760,694.00 |
| Mar 31, 2021 | -1.05 Mn |
| Dec 31, 2020 | -1.22 Mn |